OncoHULA· @OncoHULA · X·· 23 hours agoScore70
Body · original
A new SoC in cisplatin ineligible muscle-invasive bladder cancer: The VOLGA Trial. Neoadjuvant Durva plus EV, without adjuvant EV. Less is more. #BladderCancer #ESMO26 @myESMO @sogug1 @_SEOM
35 views · 0 likes · 0 reposts · 0 replies
Conference abstracts
LBA2matched by Presidential Symposium I
Perioperative durvalumab with or without tremelimumab plus neoadjuvant enfortumab vedotin in muscle-invasive bladder cancer: Results from the phase 3 VOLGA trial
https://esmocongress.esmo.orgVOLGA
https://esmocongress.esmo.orgSource: OncoHULA · x.com